Jourik Gietema

Prof. Jourik Gietema is a Professor at the Faculty of Medical Sciences, University of Groningen, affiliated with the University Medical Center Groningen (UMCG). His research focuses on medical oncology, particularly late effects of cancer treatment and testicular cancer. He holds positions in the Innovative Clinical Studies and Long-term Treatment Consequences in Cancer department and contributes to international collaborations. Key areas of expertise include chemotherapy impacts, cancer survivorship, and genetic susceptibility to tumors. He has supervised 21 PhD students and is actively involved in clinical guidelines and oncology networks.

Research interests emphasize long-term consequences of oncological treatments, including cardiovascular risks and metabolic syndrome in survivors. His work addresses sustainable development goals related to health and well-being. Recent articles explore immunotherapy outcomes, genetic associations in testicular cancer, and real-world drug efficacy.

Prof. Gietema has received grants, such as a €606,200 award for studying physical activity's role in reducing cardiovascular morbidity post-chemotherapy. He participates in academic activities like conferences and organizational roles in oncology networks. His contributions include datasets on cancer treatment protocols and media engagements discussing advancements in oncology care.